Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

PGMS-pathway control state

From Bioblast
Revision as of 14:48, 18 November 2016 by Beno Marija (talk | contribs)


high-resolution terminology - matching measurements at high-resolution


PGMS-pathway control state

Description

PGMS

PGMS: Pyruvate & Glutamate & Malate & Succinate.

MitoPathway control state: NS

2-oxoglutarate is produced through the citric acid cycle from citrate by isocitrate dehydrogenase, from oxaloacetate and glutamate by the transaminase, and from glutamate by the glutamate dehydrogenase. If the 2-oxoglutarate carrier does not outcompete these sources of 2-oxoglutarate, then the TCA cycle operates in full circle with external pyruvate&malate&glutamate&succinate

Abbreviation: PGMS

Reference: Gnaiger 2014 MitoPathways - Chapter 5.6


MitoPedia concepts: Respiratory state, SUIT state 


MitoPedia topics: EAGLE 

PGMS(L)

PGMS(P)

PGMS(E)

Discussion

Recent studies showed that S- and NS-linked OXPHOS capacity is inhibited by 2 mM malate concentrations as applied in many SUIT protocols. This inhibition is less pronounced at higher succinate concentrations (10 mM up to 50 mM S).